Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combined Collagen Crosslinking/Ultraviolet-A and Photorefractive Keratectomy or LASIK in Forme Fruste Keratoconus or Eyes With Potentially Elevated Risk of Ectasia

NCT01726283 is registered in ClinicalTrials.gov with Cxlusa as lead sponsor.

NCT NCT01726283
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01726283 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combined Collagen Crosslinking/Ultraviolet-A and Photorefractive Keratectomy or LASIK in Forme Fruste Keratoconus or Eyes With Potentially Elevated Risk of Ectasia
Lead sponsor
Cxlusa
Phase
Observational
Overall status
Completed
Start date
October 31, 2011
Completion date
July 31, 2014
Enrollment
22 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

fruste keratoconus, risk of ectasia